ArticleArchives of microbiology2025
Metabolic and fermentation engineering of Klebsiella Pneumoniae for high-level production of 3-hydroxypropionic acid.
Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Redox-based dual-substrate fermentation enhances sustainable production of 3-hydroxypropionic acid by recombinant E. coli.Applied microbiology and biotechnology · 2026Article
- Multi-omics-guided metabolic engineering of Limosilactobacillus reuteri for high-level 3-hydroxypropionaldehyde production from glucose.Microbial cell factories · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
3-hydroxypropionic acid (3-HP) is an essential C3 platform chemical with considerable potential for synthesizing various chemicals and biodegradable materials. However, efficient production of 3-HP is still an urgent problem. In this study, a comprehensive approach involving the screening and mutation of KGSADH, along with the optimization of ribosome binding sites (RBS), promoters, and the downregulation of competing metabolic pathways, led to a marked improvement in 3-HP production, achieving a concentration of 6.67 g/L in shake flask cultures. Furthermore, innovatively changing inducible promoters to achieve constitutive protein expression. Then replacing yeast extract with corn steep liquor resulted in a notable increase in 3-HP titer, rising from 86.80 to 102.56 g/L. The reduction of residual glycerol concentrations to below 25 g/L further enhanced production, culminating in a final titer of 110.70 g/L, which is the highest titer for 3-HP production in Klebsiella pneumoniae to date. These findings underscore the potential of engineered microbial systems in optimizing the sustainable production of valuable platform chemicals from renewable feedstocks.
Indexed as
Identifiers
40663134What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.